Helex designs, validates and delivers therapy specific gRNAs using its proprietary genomics data, bioinformatics and intelligent data-driven platform to companies advancing CRISPR based genome editing therapeutics. Helex is a partner from lab to commercialization, ultimately helping therapeutic companies fasten their time to market.